These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30191639)

  • 1. Hypoxia-inducible transgelin 2 selects epithelial-to-mesenchymal transition and γ-radiation-resistant subtypes by focal adhesion kinase-associated insulin-like growth factor 1 receptor activation in non-small-cell lung cancer cells.
    Kim IG; Lee JH; Kim SY; Hwang HM; Kim TR; Cho EW
    Cancer Sci; 2018 Nov; 109(11):3519-3531. PubMed ID: 30191639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APBB1 reinforces cancer stem cell and epithelial-to-mesenchymal transition by regulating the IGF1R signaling pathway in non-small-cell lung cancer cells.
    Lee JH; Kim JY; Kim SY; Choi SI; Kim KC; Cho EW; Kim IG
    Biochem Biophys Res Commun; 2017 Jan; 482(1):35-42. PubMed ID: 27836546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-induced SM22α in A549 cells activates the IGF1R/PI3K/Akt pathway, conferring cellular resistance against chemo- and radiation therapy.
    Kim TR; Cho EW; Paik SG; Kim IG
    FEBS Lett; 2012 Feb; 586(4):303-9. PubMed ID: 22245152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.
    Nurwidya F; Takahashi F; Kobayashi I; Murakami A; Kato M; Minakata K; Nara T; Hashimoto M; Yagishita S; Baskoro H; Hidayat M; Shimada N; Takahashi K
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):332-8. PubMed ID: 25446090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1.
    Lee JH; Choi SI; Kim RK; Cho EW; Kim IG
    Sci Rep; 2018 Jul; 8(1):10711. PubMed ID: 30013043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of epithelial-mesenchymal transition in IGF1R-induced resistance to EGFR-TKIs in advanced non-small cell lung cancer.
    Zhou J; Wang J; Zeng Y; Zhang X; Hu Q; Zheng J; Chen B; Xie B; Zhang WM
    Oncotarget; 2015 Dec; 6(42):44332-45. PubMed ID: 26554308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.
    Lee YJ; Han HJ
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1263-75. PubMed ID: 20015942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of Notch1 signaling in malignant progression of A549 cells subjected to prolonged cadmium exposure.
    Fujiki K; Inamura H; Miyayama T; Matsuoka M
    J Biol Chem; 2017 May; 292(19):7942-7953. PubMed ID: 28302721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aurora B induces epithelial-mesenchymal transition by stabilizing Snail1 to promote basal-like breast cancer metastasis.
    Zhang J; Lin X; Wu L; Huang JJ; Jiang WQ; Kipps TJ; Zhang S
    Oncogene; 2020 Mar; 39(12):2550-2567. PubMed ID: 31996785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling.
    Kim IG; Kim SY; Choi SI; Lee JH; Kim KC; Cho EW
    Oncogene; 2014 Jul; 33(30):3908-17. PubMed ID: 24013232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
    Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Akt2 mediates TGF-β1-induced epithelial to mesenchymal transition by deactivating GSK3β/snail signaling pathway in renal tubular epithelial cells.
    Lan A; Qi Y; Du J
    Cell Physiol Biochem; 2014; 34(2):368-82. PubMed ID: 25059120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
    Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U
    BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoplasmic aryl hydrocarbon receptor regulates glycogen synthase kinase 3 beta, accelerates vimentin degradation, and suppresses epithelial-mesenchymal transition in non-small cell lung cancer cells.
    Li CH; Liu CW; Tsai CH; Peng YJ; Yang YH; Liao PL; Lee CC; Cheng YW; Kang JJ
    Arch Toxicol; 2017 May; 91(5):2165-2178. PubMed ID: 27752740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HSPA1L Enhances Cancer Stem Cell-Like Properties by Activating IGF1Rβ and Regulating β-Catenin Transcription.
    Choi SI; Lee JH; Kim RK; Jung U; Kahm YJ; Cho EW; Kim IG
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32971893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cypripedin diminishes an epithelial-to-mesenchymal transition in non-small cell lung cancer cells through suppression of Akt/GSK-3β signalling.
    Treesuwan S; Sritularak B; Chanvorachote P; Pongrakhananon V
    Sci Rep; 2018 May; 8(1):8009. PubMed ID: 29789636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of non‑small cell lung cancer via regulating GSK-3β/β-catenin signaling.
    Geng F; Jiang Z; Song X; Zhou H; Zhao H
    Int J Oncol; 2017 Dec; 51(6):1898-1908. PubMed ID: 29039479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nogo-B receptor promotes epithelial-mesenchymal transition in non-small cell lung cancer cells through the Ras/ERK/Snail1 pathway.
    Wu D; Zhao B; Qi X; Peng F; Fu H; Chi X; Miao QR; Shao S
    Cancer Lett; 2018 Apr; 418():135-146. PubMed ID: 29331415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bidirectional signaling between TM4SF5 and IGF1R promotes resistance to EGFR kinase inhibitors.
    Choi J; Kang M; Nam SH; Lee GH; Kim HJ; Ryu J; Cheong JG; Jung JW; Kim TY; Lee HY; Lee JW
    Lung Cancer; 2015 Oct; 90(1):22-31. PubMed ID: 26190015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.
    Han MZ; Xu R; Xu YY; Zhang X; Ni SL; Huang B; Chen AJ; Wei YZ; Wang S; Li WJ; Zhang Q; Li G; Li XG; Wang J
    J Exp Clin Cancer Res; 2017 Nov; 36(1):155. PubMed ID: 29110682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.